Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **D-alanyl-D-alanine moiety of peptidoglycan precursor** is a dipeptide structure found at the terminal end of the pentapeptide stem in peptidoglycan precursors of most Gram-positive and Gram-negative bacteria. It serves as the critical substrate for the transpeptidase enzymes (also known as penicillin-binding proteins), which cross-link the peptide stems and form the rigid, mesh-like cell wall. This moiety is the specific binding site for glycopeptide antibiotics such as vancomycin, which inhibit cell wall biosynthesis by forming stable complexes with the D-Ala-D-Ala dipeptide, thereby blocking access of transpeptidases and preventing proper cell wall cross-linking. Modification of this moiety to D-Ala-D-Lac or D-Ala-D-Ser is a known mechanism of resistance in clinical pathogens, dramatically reducing antibiotic binding affinity. The D-Ala-D-Ala motif is critical for bacterial survival, cell shape maintenance, and rigidity, and its biosynthesis involves dedicated ligases that join two D-alanine residues before attachment to the growing peptidoglycan chain. The presence or replacement of D-Ala-D-Ala is a key biomarker for antibiotic susceptibility and resistance in bacterial infections.
Inhibition of peptidoglycan cross-linking by direct binding to D-Ala-D-Ala, blocking transpeptidase activity (vancomycin and similar glycopeptides)\nCompetitive inhibition of D-Ala-D-Ala ligase by structural mimicry (β-lactams and D-cycloserine)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine moiety of peptidoglycan precursor (D-Ala-D-Ala).